z-logo
open-access-imgOpen Access
Chronic Myeloid Leukemia in a Patient with Hepatitis B Virus Infection: A Case Report
Author(s) -
Ali Hailan Yousef Mohammed,
Mudawi Deena,
Yassin Mohamed A.
Publication year - 2021
Publication title -
case reports in oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.365
H-Index - 19
ISSN - 1662-6575
DOI - 10.1159/000516747
Subject(s) - case report
Chronic myeloid leukemia (CML) is a myeloproliferative disorder diagnosed by demonstrating the Philadelphia chromosome (Ph) or the BCR-ABL fusion gene. Tyrosine kinase inhibitors (TKIs) are the standard of therapy. There are increasing reports of hepatitis B virus reactivation (HBVr) in patients on this treatment. We report a case of a 46-year-old male patient diagnosed to have CML in the chronic phase and resolved hepatitis B infection. He was treated with imatinib as upfront therapy for CML and with lamivudine as prophylaxis against HBVr. The patient tolerated both treatments well with no adverse effects. The aim is to address the deficiencies in the literature in regard to managing these patients, prevention, and follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here